Literature DB >> 10413955

Influence of microbiota in experimental cutaneous leishmaniasis in Swiss mice.

M R de Oliveira1, W L Tafuri, J R Nicoli, E C Vieira, M N Melo, L Q Vieira.   

Abstract

Infection of Swiss/NIH mice with Leishmania major was compared with infection in isogenic resistant C57BL/6 and susceptible BALB/c mice. Swiss/NIH mice showed self-controlled lesions in the injected foot pad. The production of high levels of interferon-gamma (IFN-gamma) and low levels of interleukin-4 (IL-4) by cells from these animals suggests that they mount a Th1-type immune response. The importance of the indigenous microbiota on the development of murine leishmaniasis was investigated by infecting germfree Swiss/NIH in the hind footpad with L. major and conventionalizing after 3 weeks of infection. Lesions from conventionalized Swiss/NIH mice were significantly larger than conventional mice. Histopathological analysis of lesions from conventionalized animals showed abscesses of variable shapes and sizes and high numbers of parasitized macrophages. In the lesions from conventional mice, besides the absence of abscess formation, parasites were rarely observed. On the other hand, cells from conventional and conventionalized mice produced similar Th1-type response characterized by high levels of IFN-gamma and low levels of IL-4. In this study, we demonstrated that Swiss/NIH mice are resistant to L. major infection and that the absence of the normal microbiota at the beginning of infection significantly influenced the lesion size and the inflammatory response at the site of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413955     DOI: 10.1590/s0036-46651999000200005

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  5 in total

1.  Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation.

Authors:  Ciara Gimblet; Jacquelyn S Meisel; Michael A Loesche; Stephen D Cole; Joseph Horwinski; Fernanda O Novais; Ana M Misic; Charles W Bradley; Daniel P Beiting; Shelley C Rankin; Lucas P Carvalho; Edgar M Carvalho; Phillip Scott; Elizabeth A Grice
Journal:  Cell Host Microbe       Date:  2017-06-29       Impact factor: 21.023

2.  Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice.

Authors:  P L Jacob; J A Leite; A K A Alves; Y K S Rodrigues; F M Amorim; P L N Néris; M R Oliveira; S Rodrigues-Mascarenhas
Journal:  Parasitol Res       Date:  2012-10-04       Impact factor: 2.289

3.  Compartmentalized control of skin immunity by resident commensals.

Authors:  Shruti Naik; Nicolas Bouladoux; Christoph Wilhelm; Michael J Molloy; Rosalba Salcedo; Wolfgang Kastenmuller; Clayton Deming; Mariam Quinones; Lily Koo; Sean Conlan; Sean Spencer; Jason A Hall; Amiran Dzutsev; Heidi Kong; Daniel J Campbell; Giorgio Trinchieri; Julia A Segre; Yasmine Belkaid
Journal:  Science       Date:  2012-07-26       Impact factor: 47.728

Review 4.  The microbiome in patients with atopic dermatitis.

Authors:  Amy S Paller; Heidi H Kong; Patrick Seed; Shruti Naik; Tiffany C Scharschmidt; Richard L Gallo; Thomas Luger; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2018-11-23       Impact factor: 10.793

5.  Investigating associations between intestinal alterations and parasite load according to Bifidobacterium spp. and Lactobacillus spp. abundance in the gut microbiota of hamsters infected by Leishmania infantum.

Authors:  Fabine Correia Passos; Marcelo Biondaro Gois; Adenilma Duranes Sousa; Ananda Isis Lima de Marinho; Laura Corvo; Manoel Soto; Manoel Barral-Netto; Aldina Barral; Gyselle Chrystina Baccan
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-11-30       Impact factor: 2.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.